Skip to content

Initial Experience With Spatial Resynchronization Therapy in Patients With Atrial Fibrillation

Initial Experience With Spatial Resynchronization Therapy in Patients With Atrial Fibrillation

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05461612
Acronym
SR-TheAF
Enrollment
30
Registered
2022-07-18
Start date
2022-06-23
Completion date
2023-12-31
Last updated
2022-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Keywords

Atrial Fibrillation, Spatial Resynchronization

Brief summary

Demonstrate initial safety and performance of Spatial Resynchronization Therapy (SRT) in patients with persistent atrial fibrillation.

Detailed description

This is an acute study to test the ability of a custom external device (MAX-SRS) to sense atrial rhythms, determine when AF is present and deliver spatial resynchronization therapy (SRT) to terminate AF. Patients will have commercially available diagnostic electrophysiologic catheters placed in the coronary sinus and on the heart. The catheters will be connected to the MAX-SRS. If AF is not present, standard pacing measures will be used to induce AF. Once \> 1 minute of AF is recorded, the MAX-SRS will be activated to sense the rhythm and deliver SRT pacing to terminate the AF. Up to five SRT deliveries using the same or different SRT algorithms will be attempted. After the first successful termination of AF or after five SRT attempts the study is complete for each patient. Diagnostic catheters will be removed after the conclusion of the SRT pacing study.

Interventions

DEVICESpatial Resynchronization Therapy delivered by the MAX-SRS, external recording and stimulation device

Delivery of algorithmically defined pacing stimuli over a multitude of electrodes placed on the left atrium.

Sponsors

Maxwell Biomedical
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Have AF that persists (Persistent AF) for more than 7 days but less than 1 year; OR has required cardioversion for termination of AF in the past 6 months; AND is not due to a reversible cause. * Be scheduled to undergo open-heart surgery * Be able to adhere to follow-up requirements

Exclusion criteria

* Have active pericarditis or any systemic infection * Have left atrial thrombus (including left atrial appendage) * Have had a previous attempt to ablate atrial fibrillation * Scheduled for left atrial exclusion or excision * Have had previous surgical intervention in the left atrium, including left atrial appendage implant or exclusion * Have NYHA Class IV heart failure * Have long-standing persistent or permanent AF * Long-standing persistent AF is defined as AF that persists for greater than 1 year * Permanent AF is defined as AF where termination (sinus rhythm) is no longer pursued * Have any condition that prevents placement of a catheter on the posterior wall of the left atrium * History of Left Atrium (LA) infarction

Design outcomes

Primary

MeasureTime frameDescription
Ability of test system (MAX-SRS) to record AF60 secondsRecord 1 run of AF = 60 seconds, categorical variable (Yes/No)
Mean SRT pacing duration per SRT pacing attemptmin:sec/attemptRecord duration (min:sec) of each SRT pacing attempt

Secondary

MeasureTime frameDescription
Mean SRT pacing duration to convert AFMean duration (min:sec) of SRT pacing to organize clinical rhythm or terminate AF during the intra-operative procedure.Record duration (min:sec) of SRT pacing and organization of clinical rhythm (conversion to arrhythmia other than AF) or AF termination.

Other

MeasureTime frameDescription
ComplicationsAssessed post-procedure through hospital discharge (~7 days)Complications related to acute SRT pacing protocol

Countries

Georgia

Contacts

Primary ContactGeorge Khabeishvili, MD
georgekhabeishvili@icloud.com+995 599 502 255
Backup ContactElene Khabeishvili, MD
EleneKhabeishvili@outlook.com+995 555 737 300

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026